top of page

BIBLIOGRAFIA

  1. Advance Care Planning: A Parent's Perspective. (2013). BMJ Supportive & Palliative Care, 3(2), pp.276.3-276.

  2. Allard, P., Lamontagne, C., Bernard, P. and Tremblay, C. 1999. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management, 17(4), pp. 256-265.

  3. Alves, M. (2014). Editorial: Tratamento Medicamentoso para Dor. Revista Neurociências, 22(02), pp.165-166.

  4. Ashley, C., Currie, A., (Editors), 2009. The Renal Drug Handbook. 3rd ed. Oxford: Radcliffe Publishing.

  5. Azevedo, D. (2016). O Uso da Via Subcutânea em Geriatria e Cuidados Paliativos. 1st ed. Rio de Janeiro: SBGG.

  6. Back I., Watson M., Lucas C., Hoy A. and Armstrong P. 2012. Anorexia, cachexia and asthenia. Palliative Care Guidelines Plus [Online].

  7. Barbosa Neto, J., Sousa, Â., Tahamtani, S. and Ashmawi, H. (2013). Bloqueio neurolítico subaracnoideo em paciente com dor oncológica refratária: relato de caso. Revista Dor, 14(1), pp.76-77.

  8. Bausewein, C., Booth, S., Gysels, M. and Higginson I. J. 2008. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database of Systematic Reviews [Online].

  9. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1). Pain Medicine. 2009; 10(1):35–42.

  10. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001; 27:859-864

  11. Bisanz, Annette. Self-Help for Severe Constipation MD Anderson Cancer Center: Patient Education 2007: 1-4, retrieved

  12. Bjelland I, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52(2):69-77.

  13. Block SD. Assessing and managing depression in the terminally ill. Ann Inter Med. 2000; 132:209-217.

  14. Block SD. Psychological issues in end-of-life care. J Palliat Med. 2006; 9:751-772.

  15. Book reviews. (2008). Palliative Medicine, 22(2), pp.197-198.

  16. Booth, S., Bausewein, C., Higginson, I. and Moosavi, S. H. 2009. Pharmacological treatment of refractory breathlessness. Expert Review of Respiratory Medicine, 3(1), pp. 21-36.

  17. Breitbart W, Alici Y.  Agitation and delirium at the end of life. “We couldn’t manage him.” JAMA. 2008; 300(24):2898-2910.

  18. Brenner M, Chey M. An Evidence-Based Review of Novel and Emerging Therapies for Constipation inPatients Taking Opioid Analgesics. The American Journal of Gastroenterology Supplements2014; 2(1):38–46.

  19. Brietbart W, Marotta R, Platt M, et al.  A double blind trial of Haloperidol, Chlorpromazine and Lorazepam in the treatment of delirium.  Am J Psych. 1996; 153:231-237.

  20. British Geriatrics Society. 2013. Clinical Guidelines [Online]. Available: http://www.bgs.org.uk/index.php/resources-6/publicationfind/clinicalguides [Accessed 10 December 2013].

  21. British National Formulary 64. 2012. London: BMJ Group & Pharmaceutical Press. Akechi, T., Okuyama, T., Onishi, J., Morita, T. and Furukawa Toshi, A. 2008. Psychotherapy for depression among incurable cancer patients. Cochrane Database of Systematic Reviews [Online].

  22. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method of the assessment of palliative care patients. J Palliat Care. 1991; 7:6-9.

  23. Bruera, E. 2004. Pharmacological interventions in cachexia and anorexia. In: D. Doyle, G. Hanks, N. Cherny and K.Calman eds. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford: Oxford University Press.

  24. Cáceres-Jerez, L., Villa-Acuña, M. and Vera-Campos, J. (2016). Bomba intratecal de baclofeno, ¿una intervención terapéutica útil y segura en pacientes con espasticidad? Presentación de casos. IATREIA, 29(4).

  25. Candy, B., Jones, L., Goodman Margaret, L., Drake, R. and Tookman, A. 2011. Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database of Systematic Reviews [Online].

  26. Carvalho, R. and Parson, H. (2012). Manual de Cuidados Paliativos ANCP. 2nd ed. São Paulo: ANCP.

  27. Chan, K.-S., Tse, D. M. V., Sham, M. M. K. and Thorsen, A. B. 2010. Palliative medicine in malignant respiratory diseases. In: G. Hanks, Ni. Cherny, Na. Christakis, M. Fallon, S. Kaasa and Rk. Portenoy, eds. Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press.

  28. Cherny, A., Fallon, A., Kaasa, T., Portenoy, U. And Currow, A. (2015). Oxford textbook of palliative medicine. 5th ed. Oxford: Oxford University Press.

  29. Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain. The New England Journal of Medicine. 2014; 370(25): 2387–96.

  30. Chochinov HM, Wilson K, Enns G, et al. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry. 1997; 154(5):674-676.

  31. Choi YS, Billings JA. Opioid Antagonists: A Review of Their Role in Palliative Care, Focusing on Use in Opioid-Related Constipation. Journal of Pain and Symptom Management. 2002; 24(1): 71–90.

  32. Clark, K., Byfieldt, N., Dawe, M. and Currow, D. C. 2012. Treating Constipation in Palliative Care: The Impact of Other Factors Aside From Opioids. American Journal of Hospice and Palliative Medicine, 29(2), pp.122-5

  33. Clemens, K. E., Faust, M., Jaspers, B. and Mikus, G. 2013. Pharmacological treatment of constipation in palliative care. Current Opinion in Supportive Palliative Care, 7(2), pp. 183-91.

  34. Connolly, M. and Larkin, P. 2012. Managing constipation: a focus on care and treatment in the palliative setting. British Journal of Community Nursing, 17(2), pp. 60, 62-4, 66-7.

  35. Consenso Brasileiro de Caquexia e Anorexia em cuidados paliativos. (2011). Revista Brasileira de Cuidados Paliativos, 3.

  36. Cordioli,  V.; Gallois, C. B.; Isolan, L. (Org.). Psicofármacos: consulta rápida. 5.ed. Porto Alegre: Artmed, 2015.

  37. Cranston Josephine, M., Crockett, A. and Currow, D. 2008. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews [Online].

  38. Cryer B, Katz S, Vallejo R, Popescu A, Ueno R. A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain. Pain Medicine. 2014; 15(11): 1825–34.

  39. Curt Nuño, F., Pérez Díaz, M., López Rodríguez, M., González Cabano, M., Rodríguez Bello, C. and Camba Rodríguez, A. (2014). Tratamiento de espasmos musculares en el paciente con ataxia de Friedreich con bomba de infusión intratecal de baclofeno: a propósito de un caso. Revista de la Sociedad Española del Dolor, 21(2), pp.118-119.

  40. Davis, M. P., Dreicer, R., Walsh, D., Lagman, R. and Legrand, S. B. 2004. Appetite and cancer-associated anorexia: a review. Journal of Clinical Oncology, 22(8), pp. 1510-7.

  41. Dean, B., Stellpflug, S., Burnett, A. and Engebretsen, K. (2013). 2C or Not 2C: Phenethylamine Designer Drug Review. Journal of Medical Toxicology, 9(2), pp.172-178.

  42. Di Palma, Jack A., Julie R. Smith, and Mark vb Cleveland. Overnight Efficacy of Polyethylene Glycol Laxative. The American Journal of Gastroenterology97, no. 7 (July 2002): 1776–79.

  43. Dorman, S., Jolley, C., Abernethy, A., Currow, D., Johnson, M., Farquhar, M., Griffiths, G., Peel, T., Moosavi, S., Byrne, A., Wilcock, A., Alloway, L., Bausewein, C., Higginson, I. and Booth, S. 2009. Researching breathlessness in palliative care: Consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliative Medicine, 23(3), pp. 213-227.

  44. Ebner, N. and von Haehling, S. (2017). Highlights from the 9th Cachexia Conference. Journal of Cachexia, Sarcopenia and Muscle, 8(3), pp.508-511.

  45. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in Mechanically Ventilated Patients: Validity and Reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001; 286(21):2703-2710.

  46. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001; 29:1370-9.

  47. Ely EW, Siegel MD, Inouye SK. Deliriumin the Intensive Care Unit: An Under-Recognized Syndrome of Organ Dysfunction. Seminars in Respiratory & Critical Care Medicine. 2001; 22(2):115-126.

  48. Ely EW, Truman B. The Confusion Assessment Method for the ICU (CAM-ICU) Training Manual.  Available at: http://www.icudelirium.org/delirium/training-pages/CAM-ICU%20trainingman.2005.pdf .  Accessed April 27, 2009.

  49. Fainsinger R. 2004. Clinical Assessment & decision making in cachexia and anorexia. In: D. Doyle, G. Hanks, N. Cherny and K.Calman eds. Oxford Textbook of Palliative Medicine 3rd ed. Oxford: Oxford University Press.

  50. Fearon, K. (2011). Cancer Cachexia and Fat–Muscle Physiology. New England Journal of Medicine, 365(6), pp.565-567.

  51. Ford AC, Brenner DM, Schoenfeld PS. Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 2013; 108(10): 1566–74.

  52. Friedmann E, et al. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J. 2006; 11:152.

  53. Giese-Davis, J., Collie, K., Rancourt, K., Neri, E., Kraemer, H. and Spiegel, D. (2011). Decrease in Depression Symptoms Is Associated With Longer Survival in Patients With Metastatic Breast Cancer: A Secondary Analysis. Journal of Clinical Oncology, 29(4), pp.413-420.

  54. Goldhirsch, S., Chai, E., Meier, D. and Morris, J. (2014). Geriatric palliative care. 1st ed. Oxford University Press.

  55. Hasegawa, S. (2012). Early mesothelioma revisited. International Journal of Clinical Oncology,17(1):30-2

  56. Hayen, A., Herigstad, M. and Pattinson, K. (2013). Understanding dyspnea as a complex individual experience. Maturitas, 76(1), pp.45-50.

  57. Her Majesty’s Stationery Office (Hmso). 2013. Adults with Incapacity (Scotland) Act 2000 [Online].

  58. Hjalte F, Berggren AC, Bergendahl H, Hjortsberg C. The Direct and Indirect Costs of Opioid-Induced Constipation.Journal of Pain and Symptom Management. 2010; 40(5): 696–703.

  59. Holzer, Peter. Opioids and Opioid Receptors in the Enteric Nervous System: From a Problem in Opioid Analgesia to a Possible New Prokinetic Therapy in Humans. Neuroscience Letters. 2004; 361(1–3):192–5.

  60. Hotopf M, Chidgey J, Addington-Hall J, Ly KL.         Jefford M, Mileshkin L, Richard K, Thomson J et al.  Rapid screening for depression - validation of the Brief Case-Finding for Depression (BCD) in medical oncology and palliative care patients.  Br J Cancer. 2004; 91:900-6.

  61. International Association for Hospice and Palliative Care. 2008. The IAHPC Manual of Palliative Care [Online].

  62. Irwin, S. and Ferris, F. (2008). The Opportunity for Psychiatry in Palliative Care. The Canadian Journal of Psychiatry, 53(11), pp.713-724.

  63. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002; 30:119-41.

  64. Jadoulle, V., Rokbani, L., Ogez, D., Maccioni, J., Lories, G., Bruchon-Schweitzer, M. and Constant, A. (2006). Coping and adapting to breast cancer: a six-month prospective study. Bull Cancer, 93(7), pp.E67-72.

  65. Jamal M, Mazen, Mareya SM, Woldegeorgis F, Joswick TR, Ueno R. 848a Lubiprostone Significantly Improves Treatment Response in Non-Methadone Opioid-Induced Bowel Dysfunction Patients with Chronic, Non-Cancer Pain: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Gastroenterology 2012; 142(5):144 –145S.

  66. Johnson, M. J., Abernethy, A. P. and Currow, D. C. 2012. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan? Journal of Pain and Symptom Management, 43(3), pp. 614-624.

  67. Kinzbrunner, B. and Policzer, J. (2011). End of life care. New York: McGraw-Hill Medical Pub. Division.

  68. Klaschik E, Nauck F, Ostgathe C. Constipation--modern laxative therapy. Support Care Cancer. 2003; 11(11):679-685.

  69. Kumar L, Barker C, Emmanuel A. Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management.Gastroenterology Research and Practice.2014: 141737.

  70. Kyle, G Constipation and Palliative Care - Where Are We Now? International Journal of Palliative Nursing 2007; 13(1): 6–16.

  71. Latasch L, Zimmermann M, Eberhardt B, Jurna I. Treament of morphine-induced constipation with oral naloxone. Der Anaesthesist. 1997; 46 (3): 191–94.

  72. Lawlor PG, et al. Occurrence, causes and outcome of delirium in patients with advanced cancer. Arch Int Med. 2000;160:786-794.

  73. Librach S, Bouvette LM, De Angelis C, Farley J, Oneschuk D, Pereira JP, Syme A. Consensus Recommendations for the Management of Constipation in Patients with Advanced, Progressive Illness.Journal of Pain and Symptom Management 2010; 40(5): 761–73.

  74. Lloyd-Williams M, Friedman T, Rudd N. Criterion validation of the Edinburgh Postnatal depression  scale as a screening tool for depression  in patients with advanced metastatic cancer. J Pain Symp Man. 2000; 20:259-65.

  75. Lloyd-Williams M, Spiller J, Ward J.  Which depression  screening tools should be used in palliative care?  Pall Med. 2003; 17:40-43.

  76. Lloyd-Williams, M. 2002. Diagnosis and treatment of depression in palliative care. European Journal of Palliative Care, 9(5), pp. 186-8. National Institute for Health and Care Excellence. 2009. Depression in adults: The treatment and management of depression in adults [Online].

  77. MacRobbie, A., O’Neill, C., Sives, D., Paterson, E., O’Riordan, M., Pryde, N., Smithson, R., Boyce, S. and Winning, A. (2014). Palliative Care Guidelines - Guidelines. [online] Scottish Palliative Care Guidelines. Available at: http://www.palliativecareguidelines.scot.nhs.uk/guidelines.aspx [Accessed 12 Oct. 2017].

  78. MacRobbie, A., O’Neill, C., Sives, D., Paterson, E., O’Riordan, M., Pryde, N., Smithson, R., Boyce, S. and Winning, A. (2014). Palliative Care Guidelines - Guidelines. [online] Scottish Palliative Care Guidelines. Available at: http://www.palliativecareguidelines.scot.nhs.uk/guidelines.aspx [Accessed 12 Oct. 2017].

  79. Mahler, D., Selecky, P., Harrod, C., Benditt, J., Carrieri-Kohlman, V., Curtis, J., Manning, H., Mularski, R., Varkey, B., Campbell, M., Carter, E., Chiong, J., Ely, E., Hansen-Flaschen, J., O'Donnell, D. and Waller, A. (2010). American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease. Chest, 137(3), pp.674-691.

  80. Malta Ferrian, A., Lobato Prado, B., Buzaid, A., Cotait Maluf, F. and M. Rocha Lima, C. (2017). Manual de Oncologia Clínica do Brasil - Cuidados Paliativos. 1st ed. São Paulo: Dendrix Edição e Design Ltda.

  81. Maneeton B, Maneeton N, Srisurapanont M, Chittawatanarat K. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial. Drug Des Devel Ther. 2013; 7:657-67. doi: 10.2147/DDDT.S45575.

  82. Mental Health Foundation. 2013. Mental Health Foundation [Online]. Available: http://www.mentalhealth.org.uk/ [Accessed 10 December 2013].

  83. Mikkelsen RL, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nordic J Psychiatry. 2004; 58:65-70.

  84. Moraes, M., Barbosa Neto, J., Vanetti, T., Morais, L., Sousa, Â. and Ashmawi, H. (2013). Bloqueio do sistema nervoso simpático para tratamento de dor do membro fantasma: relato de caso. Revista Dor, 14(2), pp.155-157.

  85. Narváez Sarmiento, I., Hernández Santos, J., Tenopala Villegas, S., Jiménez Ramos, A., Cardona Hurtado, G. and Torres Huerta, J. (2010). Bomba de infusión intratecal implantable en pacientes con dolor crónico. Evaluación de la discapacidad y la calidad de vida. Revista de la Sociedad Española del Dolor, 17(6), pp.268-273.

  86. Neerkin, J. (2016). Palliative Care Pocketguide. 1st ed. London: UCL.

  87. Noble, B. (2014). Editor's Choice. BMJ Supportive & Palliative Care, 4(2), pp.121-121.

  88. Palliative Care Guidelines Plus. 2011. Depression [Online]. Available: http://book.pallcare.info/index.php?tid=49. [Accessed 10 December 2013].

  89. Pappagallo, M. Incidence, Prevalence, and Management of Opioid Bowel Dysfunction. American Journal of Surgery. 2001; 182 (5A Suppl): 11S – 18S.

  90. Parshall, M., Schwartzstein, R., Adams, L., Banzett, R., Manning, H., Bourbeau, J., Calverley, P., Gift, A., Harver, A., Lareau, S., Mahler, D., Meek, P. and O'Donnell, D. (2012). An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea. American Journal of Respiratory and Critical Care Medicine, 185(4), pp.435-452.

  91. Pitlick, M. and Fritz, D. 2013. Evidence about the pharmacological management of constipation, part 2: implications for palliative care. Home Healthcare Nurse, 31(4), pp. 207-18.

  92. Poole, K. and Froggatt, K. 2002. Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Palliative Medicine, 16(6), pp. 499-506.

  93. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A(9):1326-36.

  94. Poulsen J, Lykke CB, Olesen AE, Nilsson M, Drewes AM. Clinical Potential of Naloxegol in the Management of Opioid-Induced Bowel Dysfunction. Clinical and Experimental Gastroenterology . 2014; 7:345–58.

  95. Prieto, J., Atala, J., Blanch, J., Carreras, E., Rovira, M., Cirera, E., Espinal, A. and Gasto, C. (2005). Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation. Journal of Clinical Oncology, 23(25), pp.6063-6071.

  96. Qaseem, A., Snow, V., Shekelle, P., Casey, D. E., Jr., Cross, J. T., Jr., Owens, D. K., Clinical Efficacy Assessment Subcommittee of the American College Of, P., Dallas, P., Dolan, N. C., Forciea, M. A., Halasyamani, L., Hopkins, R. H., Jr. and Shekelle, P. 2008. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 148(2), pp. 141-6.

  97. Radbruch L., Elsner F., Trottenberg P., Strasser F. and Fearon K. 2010. Clinical practice guidelines on cancer cachexia in advanced cancer patients [Online].

  98. Rayner, L. et al. Expert opinion on detecting and treating depression in palliative care: A Delphi study. BMC Palliat. Care 10, 10 (2011).

  99. Rayner, L., Higginson, I., Price, A., Hotopf, M.,. 2010. The management of depression in palliative care: European clinical guidelines. [Online].

  100. Rayner, L., Price, A., Evans, A., Valsraj, K., Hotopf, M. and Higginson, I. J. 2011a. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliative Medicine, 25(1), pp. 36-51.

  101. Rayner, L., Price, A., Hotopf, M. and Higginson, I. J. 2011b. The development of evidence-based European guidelines on the management of depression in palliative cancer care. European Journal of Cancer, 47(5), pp. 702-12.

  102. Rayner, L., Price, A., Hotopf, M. and Higginson, I. J. 2011c. Expert opinion on detecting and treating depression in palliative care: A Delphi study. BMC Palliative Care, 10(10).

  103. Robinson JA, Crawford GB.  Identifying palliative care patients with symptoms -of depression: an algorithm. Pall Med. 2005; 19:278-87.

  104. Rocker, G., Horton, R., Currow, D., Goodridge, D., Young, J. and Booth, S. 2009. Palliation of dyspnoea in advanced COPD: Revisiting a role for opioids. Thorax, 64(10), pp. 910-915.

  105. Romeo, M., de los LLanos Gil, M., Cuadra Urteaga, J., Vilà, L., Ahlal, S., Indacochea, A., Pardo, N., Radua, J., Font, A. and Tuca, A. (2016). Outcome prognostic factors in inoperable malignant bowel obstruction. Supportive Care in Cancer, 24(11), pp.4577-4586.

  106. Shragge, J. E., Wismer, W. V., Olson, K. L. and Baracos, V. E. 2006. The management of anorexia by patients with advanced cancer: a critical review of the literature. Palliative Medicine, 20(6), pp. 623-9.

  107. Simon S.T., Higginson I. J., Booth, S., Harding, R. and Bausewein, C. 2010. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews [Online].

  108. Simon, S. T., Bausewein, C., Schildmann, E., Higginson, I. J., Magnussen, H., Scheve, C. and Ramsenthaler, C. 2013. Episodic breathlessness in patients with advanced disease: A systematic review. Journal of Pain and Symptom Management, 45(3), pp. 561-578.

  109. Smith, G. (2013). Palliative care and end-of-life decisions. New York: Palgrave Macmillan.

  110. Souza, A. and Morete, M. (2012). O uso da radiofrequência pulsátil no tratamento da dor lombar. Revista Dor, 13(2), pp.165-169.

  111. Spathis A., Davies H.E. and Booth S. 2011. Respiratory Disease: From advanced disease to bereavement. 5th ed. New York: Oxford University Press.

  112. Sykes, N. 2006. Constipation, diarrhoea, and intestinal obstruction. In: M. Fallon and D.Doyle, E. eds. ABC of Palliative Care. 2nd ed. Oxford: BMJ. pp.25-29.

  113. Sykes, N. 2010. Constipation and diarrhoea. In: G. Hanks, NI. Cherny, NA. Christakis, M. Fallon, S. Kaasa and RK. Portenoy, eds. Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press. pp 833-849.

  114. Sykes, N. 2013. Emerging Evidence on Docusate: Commentary on Tarumi et al. Journal of Pain and Symptom Management, 45(1), pp. 1.

  115. Tamayo AC, Diaz-Zuluaga PA. Management of Opioid-Induced Bowel Dysfunction in Cancer Patients.Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2004; 12(9):613–18.

  116. Tarumi Y, Wilson MP, Szafran O, and Spooner GR. Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients. Journal of Pain and Symptom Management 2013; 45(1): 2–13.

  117. Taylor, G. (2002). Clinician's guide to palliative care in management of chronic illnesses. Oxford: Blackwell Science.

  118. The Cochrane Database of Systematic Reviews - Issue 11 2012. (2012). Journal of Evidence-Based Medicine, 5(4), pp.238-239.

  119. Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ. Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness. The New England Journal of Medicine. 2008; 358 (22): 2332–43.

  120. Tremblay A and Breitbart W.  Psychiatric dimensions of palliative care. Neurol Clin. 2001; 19(4):949-67.

  121. Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-Induced Bowel Disorders and Narcotic Bowel Syndrome in Patients with Chronic Non-Cancer Pain.Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society. 2010; 22(4): 424–30, e96.

  122. Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant Laxatives and Opioid-Induced Constipation. Journal of Pain and Symptom Management. 2012; 43(2): 306–13. doi:10.1016/j.jpainsymman.2011.12.002.

  123. Twycross, R. and Wilcock, A. 2011. Palliative Care Formulary (PCF4). 4th ed. Nottingham: Palliativedrugs.com Ltd.

  124. Twycross, R., Wilcock, A. and Stark Toller, C. 2009. Symptom Management in Advanced Cancer. 4th ed. Nottingham: Palliativedrugs.com Ltd.

  125. Vodermaier, A. and Millman, R. D. 2011. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: A systematic review and meta-analysis. Supportive Care in Cancer, 19(12), pp. 1899-1908.

  126. Volicer L, Lane P, Panke J, Lyman P. Management of Constipation in Residents with Dementia: Sorbitol Effectiveness and Cost. Journal of the American Medical Directors Association 2005; 6(3): S32–34.

  127. Wasteson, E., Brenne, E., Higginson, I. J., Hotopf, M., Lloyd-Williams, M., Kaasa, S. and Loge, J. H. 2009. Depression assessment and classification in palliative cancer patients: A systematic literature review. Palliative Medicine, 23(8), pp. 739-753.

  128.  Whooley, M., Avins, A., Miranda, J. and Browner, W. (1997). Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine, 12(7), pp.439-445.

  129. Yennaurjalingam S et al. Pain and terminal delirium research in the elderly. Clin Geriatr Med. 2005;21(1):93-119.

bottom of page